Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations.
Nishiyama U, Yoshino T, Ozai M, Yoshioka R, Fujisawa M, Ogasawara Y, Kitahori M, Yoshioka E, Kubo K, Komeno Y, Kurokawa M, Ogawa S, Chiba S, Osawa T, Kuwaki T, Hirai H, Miwa A.
Nishiyama U, et al. Among authors: kuwaki t.
Leuk Res. 2006 Dec;30(12):1541-6. doi: 10.1016/j.leukres.2006.02.028. Epub 2006 Apr 17.
Leuk Res. 2006.
PMID: 16603240